EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exploring Immune-Related Biomarkers in Human Itch

Giulia Coscarella iD, Gil Yosipovitch

Dermatitis® · 2025

DOI: 10.1089/derm.2025.0014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatitis®, 2025. Verfasst von Giulia Coscarella und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Pruritus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Itch is a debilitating symptom that affects ∼40% of the population and significantly impacts patients’ quality of life. The management of chronic itch remains a significant challenge due to the limited availability of reliable biomarkers for assessing its severity. This review aims to investigate the key neuroimmune-related biomarkers involved in the pathophysiology of itch and itch-dependent diseases. A thorough literature review was conducted using PubMed and Google Scholar, employing search terms like “Biomarkers” OR “Blood markers” OR “Immune-related” AND “Itch” OR “Pruritus.” Recent evidence has highlighted the central role of neuro-immune-epithelial crosstalk in itch pathogenesis, with pruritogens stimulating the release of interleukin-33 (IL-33), thymic stromal lymphopoietin, and periostin, which promote Th2 inflammation and intensify itch sensation. Elevated levels of cytokines such as IL-4, IL-13, and IL-31 have been associated with various inflammatory skin conditions, though their correlation with itch severity remains inconsistent. Chemokines like thymus and activation-regulated chemokine, as well as CC motif chemokine ligand, have demonstrated promise as biomarkers for Th2-mediated conditions, showing correlations with disease severity and itch intensity. Additional markers, such as brain natriuretic peptide and its metabolite NT-proBNP, have been correlated with itch intensity in chronic pruritic conditions. However, neuropeptides like substance P have shown limited utility in evaluating itch severity. Understanding the mechanisms underlying itch through immune-related biomarkers could lead to more effective treatments and enhance patient outcomes while providing insights into immune dysregulation in pruritic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PruritusHumansBiomarkersCytokinesThymic Stromal LymphopoietinInterleukin-33Cell Adhesion MoleculesNatriuretic Peptide, BrainTh2 Cells

Substanzen

BiomarkersCytokinesThymic Stromal LymphopoietinInterleukin-33Cell Adhesion MoleculesPOSTN protein, humanNatriuretic Peptide, Brain

Autor:innen und Institutionen

  • From the Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
  • UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy.
  • Dr. Phillip Frost Dept of Dermatology and Cutaneous Surgery, Miami Itch Center, University of Miami Miller School of Medicine, Coral Gables, FL, USA.

ORCID-Profile: Giulia Coscarella

Zitieren

APA

Coscarella, G., & Yosipovitch, G. (2025). Exploring Immune-Related Biomarkers in Human Itch. Dermatitis®. https://doi.org/10.1089/derm.2025.0014

Vancouver

Coscarella G, Yosipovitch G. Exploring Immune-Related Biomarkers in Human Itch. Dermatitis®. 2025. doi:10.1089/derm.2025.0014

BibTeX
@article{Coscarella2025,
  author = {Coscarella, Giulia and Yosipovitch, Gil},
  title = {Exploring Immune-Related Biomarkers in Human Itch},
  journal = {Dermatitis®},
  year = {2025},
  doi = {10.1089/derm.2025.0014}
}
Kostenlos starten →